{"transactions":[{"id":3693089,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-18T01:51:14.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, January 11, 2019. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":50000,"derivative":{"exercise_price":9.1,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-19-002348","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465919002348/a4.xml","form_type":"4"}},{"id":3693088,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-18T01:51:14.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 25,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, January 11, 2019.  The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":163688,"source":{"system":"sec-edgar","filing":"0001104659-19-002348","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465919002348/a4.xml","form_type":"4"}},{"id":4003446,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-10T00:12:04.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan.  The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date.  The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of the Vesting Commencement Date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":65000,"derivative":{"exercise_price":28.72,"expiration_date":"2028-03-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001104659-18-016415","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918016415/a4.xml","form_type":"4"}},{"id":4023939,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":4063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of February 8, 2017, and 1/48th of the shares underlying such option vesting monthly thereafter.  This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3."}],"balance_after":60937,"derivative":{"exercise_price":11.83,"expiration_date":"2027-02-08","underlying":"Common Stock","underlying_shares":4063},"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023938,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option. This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of February 1, 2016, and 1/48th of the shares underlying such option vesting monthly thereafter.  This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3."}],"balance_after":35000,"derivative":{"exercise_price":11.09,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023937,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":4376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option.  This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of August 1, 2015, and 1/48th of the shares underlying such option vesting monthly thereafter.  This Form 4 also aggregates identical options which were reported separately on the reporting person's Form 3."}],"balance_after":28570,"derivative":{"exercise_price":8.33,"expiration_date":"2025-08-25","underlying":"Common Stock","underlying_shares":4376},"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023936,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":2184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person's Form 3, filed on July 7, 2017, erroneously reported the vesting schedule of this option.  This option is scheduled to vest over four years in equal monthly installments, with 1/48th of the shares underlying such option vesting on the one-month anniversary of January 1, 2015, and 1/48th of the shares underlying such option vesting monthly thereafter."}],"balance_after":12957,"derivative":{"exercise_price":7.27,"expiration_date":"2025-04-25","underlying":"Common Stock","underlying_shares":2184},"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023935,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":15623,"price":30,"value":468690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":138688,"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023934,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":4063,"price":11.83,"value":48065.29,"ownership":{"direct":true},"balance_after":154311,"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023933,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":5000,"price":11.09,"value":55450.0,"ownership":{"direct":true},"balance_after":150248,"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023932,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":4376,"price":8.33,"value":36452.08,"ownership":{"direct":true},"balance_after":145248,"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}},{"id":4023931,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":160987,"kind":"person","name":"Sah Dinah Ph.D.","position":1,"cik":"0001711043","reported_name":"Sah Dinah Ph.D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-01T23:00:41.000Z","date":"2018-02-27","kind":"exercise","acquired":false,"shares":2184,"price":7.27,"value":15877.68,"ownership":{"direct":true},"balance_after":140872,"source":{"system":"sec-edgar","filing":"0001104659-18-014162","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465918014162/a4.xml","form_type":"4"}}]}